Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study) by Nicolas Bertrand, MD, Pierre Guerreschi, MD, PhD, Nicole Basset-Seguin, MD, PhD, Philippe Saiag, MD, PhD, Alain Dupuy, MD, PhD, Sophie Dalac-Rat, MD, Véronique Dziwniel, PhD, César Depoortère, MD, Alain Duhamel, MD, PhD, Laurent Mortier, MD, PhD

Get full text

Differential gradients of immunotherapy vs targeted therapy efficacy according to the sun-exposure pattern of the site of occurrence of primary melanoma: a multicenter prospective... by David Russo, Stéphane Dalle, Olivier Dereure, Laurent Mortier, Sophie Dalac-Rat, Caroline Dutriaux, Marie-Thérèse Leccia, Marie-Thérèse Leccia, Delphine Legoupil, Henri Montaudié, Eve Maubec, Julie De Quatrebarbes, Jean-Philippe Arnault, Florence Granel Brocard, Philippe Saïag, Brigitte Dreno, Clara Allayous, Clara Allayous, Bastien Oriano, Wendy Lefevre, Céleste Lebbé, Céleste Lebbé, Lise Boussemart, Lise Boussemart

Get full text

Impact of the Covid‐19 pandemic on melanoma diagnosis: A retrospective study from the French clinical database of melanoma patients (RIC‐Mel) by François Skowron, Stéphane Mouret, Arnaud Seigneurin, Henri Montaudié, Eve Maubec, Florent Grange, Gaelle Quereux, Philippe Célérier, Mona Amini‐Adle, Sophie Dalac‐Rat, Julie De Quatrebarbes, Ouidad Zehou, Abed Safia, Philippe Muller, Philippe Modiano, Laurent Misery, Noemie Litrowski, Florence Brunet‐Possenti, Laurent Mortier, Guido Bens, Alice Hervieu, Nicolas Leduc, Thomas Jouary, Candice Lesage, Nathalie Beneton, Yannick Le Corre, Lionnel Geoffrois, Domitille Thomas‐Beaulieu, Ewa Hainaut, Marie‐Thérèse Leccia

Get full text